Aligos Therapeutics, Inc.
MODIFIED GAPMER OLIGONUCLEOTIDES AND METHODS OF USE

Last updated:

Abstract:

The disclosure includes antisense oligonucleotides, including gapmer antisense oligonucleotides, along with methods of making and use, e.g., against HBV.

Status:
Application
Type:

Utility

Filling date:

29 May 2020

Issue date:

10 Dec 2020